Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Officer of SI-BONE, Inc., filed a Form 4 on November 6, 2026, disclosing a sale of 36,241 shares of common stock on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: 36,241 shares of SI-BONE, Inc. common stock were disposed of on November 4, 2026.
  • Weighted average price: The sale was reported at a weighted average price of $24.8007 per share, with individual trades ranging from $24.00 to $25.25.
  • 10b5-1 plan: The transaction was executed pursuant to a Rule 10b5-1 trading plan dated June 13, 2025.
  • Indirect holdings after sale: Following the transaction, Pisetsky holds 40,167 shares indirectly through the Michael Pisetsky Sep Prop Tr.
  • Direct holdings: 164,444 shares are reported as directly beneficially owned, including 124,139 shares issuable upon settlement of restricted stock units.
  • RSU detail: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock, according to the filing.

Pisetsky's November 2026 SI-BONE Share Sale: Filing Details

Michael A. Pisetsky, identified in the filing as SVP, Ops & Adm/Chief Legal Officer of SI-BONE, Inc. (NASDAQ:SIBN), reported the disposition of 36,241 shares of common stock on November 4, 2026. The transaction carried transaction code "S," indicating a sale. According to the filing, the sale was effected pursuant to a 10b5-1 trading plan dated June 13, 2025, and the box indicating compliance with Rule 10b5-1(c) was checked on the form.

The filing states the sale was executed in multiple trades at prices ranging from $24.00 to $25.25 per share. The weighted average sale price reported is $24.8007. The filing notes that Pisetsky "undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."

Following the reported transaction, the filing discloses that Pisetsky indirectly holds 40,167 shares through the Michael Pisetsky Sep Prop Tr. Additionally, 164,444 shares are reported as directly beneficially owned. Of that direct total, 124,139 shares are described as "issuable on settlement of restricted stock units granted to the Reporting Person," with each RSU representing a contingent right to receive one share of the issuer's common stock.

What Was Disclosed

The Form 4 discloses a sale of 36,241 SI-BONE common shares by the company's Chief Legal Officer on November 4, 2026, under a pre-established 10b5-1 plan, with a weighted average price of $24.8007 and remaining beneficial ownership reported across direct and trust-held positions.